Balakumar P - Search Results

1

Prevalence and prevention of cardiovascular disease and diabetes mellitus.

Balakumar P, Maung-U K, Jagadeesh G. Balakumar P, et al. Pharmacol Res. 2016 Nov;113(Pt A):600-609. doi: 10.1016/j.phrs.2016.09.040. Epub 2016 Sep 30. Pharmacol Res. 2016. PMID: 27697647 Review.

2

PPAR dual agonists: are they opening Pandora's Box?

Balakumar P, Rose M, Ganti SS, Krishan P, Singh M. Balakumar P, et al. Pharmacol Res. 2007 Aug;56(2):91-8. doi: 10.1016/j.phrs.2007.03.002. Epub 2007 Mar 14. Pharmacol Res. 2007. PMID: 17428674 Review.

3

PPAR ligands: are they potential agents for cardiovascular disorders?

Balakumar P, Rose M, Singh M. Balakumar P, et al. Pharmacology. 2007;80(1):1-10. doi: 10.1159/000102594. Epub 2007 May 10. Pharmacology. 2007. PMID: 17496434 Review.

4

Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?

Balakumar P, Rohilla A, Singh M. Balakumar P, et al. Pharmacol Res. 2008 Jun;57(6):403-12. doi: 10.1016/j.phrs.2008.05.006. Epub 2008 Jun 30. Pharmacol Res. 2008. PMID: 18586514 Review.

5

Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.

Balakumar P, Chakkarwar VA, Singh M. Balakumar P, et al. Mol Cell Biochem. 2009 Jan;320(1-2):149-62. doi: 10.1007/s11010-008-9917-z. Epub 2008 Oct 2. Mol Cell Biochem. 2009. PMID: 18830571

6

Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.

Balakumar P, Sharma R, Singh M. Balakumar P, et al. Pharmacol Res. 2008 Nov-Dec;58(5-6):356-63. doi: 10.1016/j.phrs.2008.09.012. Epub 2008 Oct 2. Pharmacol Res. 2008. PMID: 18951979

7

The impairment of preconditioning-mediated cardioprotection in pathological conditions.

Balakumar P, Singh H, Singh M, Anand-Srivastava MB. Balakumar P, et al. Pharmacol Res. 2009 Jul;60(1):18-23. doi: 10.1016/j.phrs.2009.03.002. Epub 2009 Mar 13. Pharmacol Res. 2009. PMID: 19427581 Review.

8

Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions.

Balakumar P, Arora MK, Ganti SS, Reddy J, Singh M. Balakumar P, et al. Pharmacol Res. 2009 Jul;60(1):24-32. doi: 10.1016/j.phrs.2009.02.002. Epub 2009 Feb 14. Pharmacol Res. 2009. PMID: 19427582 Review.

9

Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders?

Balakumar P, Kaur J. Balakumar P, et al. Pharmacol Res. 2009 Nov;60(5):361-8. doi: 10.1016/j.phrs.2009.06.005. Epub 2009 Jun 24. Pharmacol Res. 2009. PMID: 19559087 Review.

10

Emerging role of PPAR ligands in the management of diabetic nephropathy.

Balakumar P, Arora MK, Singh M. Balakumar P, et al. Pharmacol Res. 2009 Sep;60(3):170-3. doi: 10.1016/j.phrs.2009.01.010. Epub 2009 Jan 31. Pharmacol Res. 2009. PMID: 19646656 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results